TransMedics Group, Inc. (TMDX) — Financial statements
Income statement, balance sheet, and cash flow for TransMedics Group, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 605↑37.1% | 442↑82.7% | 242↑158.5% | 93↑208.8% | 30 | |
| Cost of Revenue | 243↑35.2% | 179↑105.0% | 88↑210.5% | 28↑209.6% | 9 | |
| Gross Profit | 363↑38.4% | 262↑70.1% | 154↑136.1% | 65↑208.5% | 21 | |
| Operating Expenses | ||||||
| R&D Expenses | 69↑23.4% | 56↓11.5% | 63↑136.0% | 27↑20.2% | 22 | |
| General & Administrative Expenses | 181↑7.3% | 169↑41.0% | 120↑131.3% | 52↑35.0% | 38 | |
| Selling & Marketing Expenses | 4 | 0.00 | 0.00↓100.0% | 18 | 0.00 | |
| SG&A Expenses | 185↑9.8% | 169↑41.0% | 120↑71.0% | 70↑82.6% | 38 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 254↑13.2% | 225↑22.8% | 183↑89.0% | 97↑59.6% | 61 | |
| Total Costs & Expenses | 497↑23.0% | 404↑49.5% | 270↑116.5% | 125↑79.2% | 70 | |
| Operating Results | ||||||
| Operating Income | 109↑189.6% | 37↑230.5% | -29↑8.6% | -31↑20.3% | -39 | |
| Depreciation & Amortization | 27↑37.6% | 20↑141.6% | 8↑135.1% | 3↑91.4% | 2 | |
| EBITDA | 148↑112.3% | 70↑1008.0% | -8↑73.4% | -29↑24.8% | -38 | |
| EBIT | 121↑141.7% | 50↑416.1% | -16↑51.0% | -32↑19.5% | -40 | |
| Interest & Other Income | ||||||
| Net Interest Income | -14↑4.4% | -14↓943.1% | 2↑160.5% | -3↑27.1% | -4 | |
| Interest Income | 0.00 | 0.00↓100.0% | 13↑1288.9% | 0.90 | 0.00 | |
| Interest Expense | 14↓4.4% | 14↑33.5% | 11↑189.6% | 4↓3.8% | 4 | |
| Non-Operating Income | -13↓0.2% | -13↑1.2% | -13↓1382.1% | 1↑14.3% | 0.88 | |
| Other Income / Expenses | -1↑38.2% | -2↓183.5% | 2↑143.5% | -5↑0.5% | -5 | |
| Income Before Tax | 108↑200.5% | 36↑234.2% | -27↑26.3% | -36↑18.1% | -44 | |
| Income Tax Expense | -83↓26292.7% | 0.32↑119.2% | -2↓2589.4% | 0.07↑83.3% | 0.04 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 190↑436.6% | 35↑241.7% | -25↑30.9% | -36↑18.1% | -44 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 190↑436.6% | 35↑241.7% | -25↑30.9% | -36↑18.1% | -44 | |
| Bottom-Line Net Income | 190↑436.6% | 35↑241.7% | -25↑30.9% | -36↑18.1% | -44 | |
| EPS (Basic) | 5.60↑423.4% | 1.07↑239.0% | -0.77↑37.4% | -1.23↑23.1% | -1.60 | |
| EPS (Diluted) | 4.87↑382.2% | 1.01↑231.2% | -0.77↑37.4% | -1.23↑23.1% | -1.60 | |
| Weighted Average Shares | 34↑2.3% | 33↑2.2% | 33↑10.0% | 30↑7.0% | 28 | |
| Weighted Average Diluted Shares | 41↑15.1% | 35↑8.3% | 33↑10.0% | 30↑7.0% | 28 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.